Skip to main content
. 2023 Nov 18;17(1):155. doi: 10.1186/s13065-023-01067-1

Table 3.

Compounds 1 (af), 2 (ae), and zone of inhibition/mm's antibacterial activity

Compounds Gram positive Gram negative
Escherichia Coli Staphylococcus Aureus Klebsiella Pneumoniae Pseudomononas Aeruginosa
1a 10 12 15 18
1b 05 10 10 12
1c 14 08 13 14
1d 12 05 10 12
1e 10 10 18 10
1f 09 12 20 22
2a 10 15 26 21
2b 10 17 12 10
2c 16 20 20 22
2d 15 25 18 10
2e 17 10 20 18
DMSO
Ciprofloxacin 16 22 16 25

(–) nil active